Cargando…
The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy
BACKGROUND: Oestrogen receptor positive (ER+)/HER‐2 negative breast cancer (BC) is considered to be an immunologically cold tumour compared to triple negative breast cancer. Therefore, the tumour microenvironment (TME) of ER+/HER‐2 negative BC is understudied. The aim of this project is to investiga...
Autores principales: | Oner, Gizem, Broeckx, Glenn, Van Berckelaer, Christophe, Zwaenepoel, Karen, Altintas, Sevilay, Canturk, Zafer, Tjalma, Wiebren, Berneman, Zwi, Peeters, Marc, Pauwels, Patrick, van Dam, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524081/ https://www.ncbi.nlm.nih.gov/pubmed/37553911 http://dx.doi.org/10.1002/cam4.6425 |
Ejemplares similares
-
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Van Berckelaer, Christophe, et al.
Publicado: (2021) -
SARS-CoV-2 and cancer: Are they really partners in crime?
por: van Dam, Peter A., et al.
Publicado: (2020) -
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment
por: van Dam, Peter A., et al.
Publicado: (2015) -
Mycosis fungoides of the vulva
por: Tjalma, Wiebren A. A., et al.
Publicado: (2020) -
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
por: Najim, Omar, et al.
Publicado: (2023)